Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: Correlation with serum prostate-specific antigen

Journal of Clinical Endocrinology and Metabolism

Volumn 77, Issue 1, 1993, Pages 229-233

  Kanety, Hannah ^a   Madjar, Yigal ^a   Dagan, Yaacov ^a   Levi, Joseph ^b   Papa, Moshe Z ^a   Pariente, Clara ^a   Goldwasser, Benad ^a   Karasik, Avraham ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; GROWTH INHIBITION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; INSULIN BLOOD LEVEL; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; BLOTTING, WESTERN; CARRIER PROTEINS; COMPARATIVE STUDY; HUMAN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2; INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEINS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL;

EID: 0027326228     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.77.1.7686915     Document Type: Article

References (22)

1. Macaulay VM. 1992 Insulin-like growth factors and cancer. Br J Cancer. 65:311-320.
2. Daughaday WH, Rotwein P. 1989 Insulin-like growth factors 1 and 2. Peptide messenger ribonucleic acid, gene structures and serum and tissue concentrations. Endocr Rev. 10:68-91.
3. Daughaday WH. 1990 Editorial: the possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology. 127:1-4.
4. Ahatdauin S, Gourmelen M, Noguiez P, et al. 1989 Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab. 69:1291-1301.
5. Rosenfeld RG, Lamson GL, Hung P, et al. 1990 Insulin-like growth factor binding proteins. Recent Prog Horm Res. 46:99-163.
6. Shimasaki S, Gao L, Shimonaka M, Ling N. 1991 Isolation and molecular cloning of insulin-like growth factor binding protein-6. Mol Endocrinol. 5:938-948.
7. Elgin RD, Busby Jr WH, Clemmons DR. 1987 An insulin-like growth factor binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA. 84:3254-3258.
8. Cohen P, Peehl DM, Lamson G, Rosenfeld RG. 1991 Insulin-like growth factors (IGFs), IGF receptors, and IGF binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab. 73:401-407.
9. Cohen P, Fielder TJ, Hasegawa Y, Frisch H, Giudice LC, Rosenfeld RG. 1991 Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol (Copenh). 124(Suppl):74-85.
10. Stamey TA, Yang A, Hay AR, McNeal JE, Freiha FS, Redwine E. 1987 Prostate specific antigen is the serum marker for adenocarcinoma of the prostate. N Engl J Med. 317:909-916.
11. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. 1986 Analysis of serum insulin-like growth factor binding proteins using Western blotting: using the method for titration of binding proteins and competitive binding studies. Anal Biochem. 154:138-143.
12. Zapf J, Schmid CH, Guler HP, et al. 1990 Regulation of binding proteins for insulin-like growth factors in humans. J Clin Invest. 86:952-961.
13. Perkel VS, Mohan S, Baylink DJ, Linkhart K. 1990 An inhibitory insulin-like growth factor binding protein (In-IGFBP) from human prostatic cell condition medium reveals N-terminal sequence identity with bone derived In-IGFBP. J Clin Endocrinol Metab. 71:533-535.
14. Davies SC, Wass GAH, Ross RJM, et al. 1991 The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol. 130:469-473.
15. Counts DR, Gwirtsman H, Carlsson LMS, Lesem M, Cutler GB. 1992 The effect of anorexia and refeeding on growth hormonebinding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab. 75:762-767.
16. Clemmons DR, Underwood LE, Dickeson RM, Brown RD, Hak LJ, McPhee D. 1985 Use of somatomedin C/insulin like growth factor-1 measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr. 41:191-198.
17. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation, in the puerperium: effect of a serum associated protease activity. J Clin Endocrinol Metab. 70:806-816.
18. Donovan SM, Giudice LC, Murphy LJ, Hintz RL, Rosenfeld RG. 1991 Maternal insulin-like growth factor binding proteins mRNA during rat pregnancy. Endocrinology. 129:3359-3366.
19. Davenport ML, Isley WL, Pucilowska JB, et al. 1992 Insulin-like growth factor binding protein-3 proteolysis is induced after elective surgery. J Clin Endocrinol Metab. 75:590-595.
20. Cohen P, Graves HCB, Peehl DM. Biological effects of PSA as an IGFBP-3 protease. Proc of the 74th Annual Meet of The Endocrine Soc. 1992;291.
21. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. 1992 Prostate-specific antigen (PSA) is an insulinlike growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab. 75:1046-1053.
22. Fiorelli G, De-Bellis A, Longo A, et al. 1991 Insulin-like growth factor-1 receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with gonadotropin-releasing hormone analog. J Clin Endocrinol Metab. 72:740-746.